Connective Tissue Disease and the Lungs

22 Nov 2026 12:15 12:30
Yet Hong Khor Speaker Australia
Connective tissue diseases (CTDs) are increasingly prevalent, with lung involvement being common, which contributes to substantial morbidity and mortality. Lung involvement in CTD encompasses a broad spectrum of manifestations affecting the airways, lung parenchyma, pleura, pulmonary vasculature and respiratory muscles. Interstitial lung disease (ILD) represents one of the most frequent and clinically significant manifestations. Importantly, lung involvement may precede extra-pulmonary manifestations of CTD, creating diagnostic challenges for respiratory physicians. This presentation will provide a practical overview of the relationship between CTD and lung disease, with a particular focus on CTD-associated ILD. Management principles will also be explored, including multidisciplinary care models and the importance of tailoring treatment according to disease stage, underlying inflammatory and fibrotic mechanisms, and treatment goals. Bronchiolar disease and treatment-related pulmonary complications in CTD will be highlighted. The discussion aims to equip clinicians with practical strategies for the diagnosis and management of CTD-related lung disease in clinical practice.